HomeMCRB • NASDAQ
Follow
Seres Therapeutics Inc
Previous close
$0.78
Day range
$0.76 - $0.80
Year range
$0.73 - $6.87
Market cap
116.93M USD
Avg Volume
4.36M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 64.00K | -93.44% |
Operating expense | 12.74M | -44.74% |
Net income | -41.25M | 40.04% |
Net profit margin | -64.45K | -813.41% |
Earnings per share | -0.28 | 48.78% |
EBITDA | -37.89M | 43.17% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 127.96M | -29.43% |
Total assets | 358.60M | 2.81% |
Total liabilities | 403.46M | 19.37% |
Total equity | -44.86M | — |
Shares outstanding | 151.01M | — |
Price to book | -2.36 | — |
Return on assets | -27.21% | — |
Return on capital | -53.96% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -41.25M | 40.04% |
Cash from operations | -47.50M | 10.20% |
Cash from investing | -877.00K | -114.80% |
Cash from financing | 6.43M | 39.85% |
Net change in cash | -41.95M | 0.99% |
Free cash flow | -4.90M | 83.74% |
About
CEO
Founded
2010
Website
Employees
233